TA
HSCS icon

TFB Advisors’s Heart Test Laboratories HSCS Stock Holding History

TFB Advisors’s Portfolio HSCS Stock Details HSCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$74.8K Hold
29,740
– – 0.04% 180
2025
Q4 		$91.9K Hold
29,740
– – 0.03% 305
2025
Q3 		$105K Buy
+29,740
New +$108K 0.03% 305

Other funds holding HSCS

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ASW
Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TWM
Tradition Wealth Management Edina, Minnesota $1.41B AUM 19.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

TFB Advisors's HSCS Position: Q1 2026 in Review

TFB Advisors held its Heart Test Laboratories (HSCS) position steady in Q1 2026 at 29,740 shares worth $74.8K. The position accounts for 0.04% of the portfolio, ranked #180.

TFB Advisors first reported a position in HSCS in Q3 2025 and has held it in 3 quarters since. The position peaked at $105K in Q3 2025. 13 funds tracked by Wall St. Rank hold HSCS as of Q1 2026.

  • TFB Advisors held 29,740 shares of Heart Test Laboratories worth $74.8K as of Q1 2026.
  • TFB Advisors left its Heart Test Laboratories share count unchanged in Q1 2026.
  • Heart Test Laboratories made up 0.04% of TFB Advisors's portfolio in Q1 2026, its #180 holding.
  • TFB Advisors first reported a position in Heart Test Laboratories in Q3 2025 and has held it in 3 quarters since.
  • TFB Advisors's Heart Test Laboratories position peaked at $105K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q1 2026.

Based on TFB Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.